Mazdutide

Definition

An investigational GLP-1 + glucagon dual receptor agonist developed by Innovent Biologics, marketed in China as 信尔达 (Xinerda). Approved by China's NMPA in March 2025 for chronic weight management. Not FDA-approved or available in the United States.

GLP-1 pipeline tracker →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in drug

• Liraglutide
• Exenatide
• Dulaglutide
• Albiglutide
• Contrave
• Qsymia
• Bupropion
• Naltrexone
• Phentermine
• Topiramate
• Pemvidutide

Looking for more depth?

• GLP-1 pipeline tracker
• Browse the full GLP-1 glossary (124 terms across 8 categories)
• Research articles — primary-source deep dives
• Tools and calculators
• Compare GLP-1 telehealth providers